Cases 11 - 20 of 106
Array BioPharma, Inc. v. Eugia Pharma Specialities Limited et al
as 1:2022cv01236
Plaintiff:
Array BioPharma, Inc.
Defendant:
Eugia Pharma Specialities Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Eugia Pharma Specialities Limited et al
as 1:2022cv00688
Defendant:
Eugia Pharma Specialities Limited, Eugia Pharma Specialties Limited, Aurobindo Pharma USA, Inc. and others
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00377
Plaintiff:
MSD International Business GmbH, MSD International GmbH, Pfizer Inc. and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00227
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Aurobindo Pharma Limited et al
as 1:2022cv00037
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01735
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01707
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA S.A., BIAL - HOLDING, S.A. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01682
Plaintiff:
BIAL - PORTELA & CA S.A., BIAL - HOLDING, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Healthcare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01575
Plaintiff:
Bayer Healthcare LLC and Meda Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
